GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Adora2a | multiple interactions | EXP | | 6480464 | CTD | [2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine binds to ADORA2A protein] which results in decreased susceptibility to Rotenone; [ZM 241385 binds to ADORA2A protein] which results in decreased susceptibility to Rotenone | PMID:19416678 | Adora2a | increases expression | ISO | Adora2a (Mus musculus) | 6480464 | CTD | Rotenone results in increased expression of ADORA2A mRNA | PMID:31820278 PMID:32937126 | Adora2a | multiple interactions | ISO | Adora2a (Mus musculus) | 6480464 | CTD | [Curcumin co-treated with Niacin co-treated with ZM 241385] inhibits the reaction [Rotenone results in increased expression of ADORA2A mRNA]; carbidopa, levodopa drug combination inhibits the reaction [Rotenone results in increased expression of ADORA2A mRNA]; Curcumin inhibits the reaction [Rotenone results in increased expression of ADORA2A mRNA]; Niacin inhibits the reaction [Rotenone results in increased expression of ADORA2A mRNA]; ZM 241385 inhibits the reaction [Rotenone results in increased expression of ADORA2A mRNA] | PMID:31820278 | |
Go Back to source page | Continue to Ontology report |